Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2591 (LINC02591) is a human gene encoding a long intergenic non-coding RNA (lincRNA), which are defined as RNA molecules longer than 200 nucleotides that do not overlap with protein-coding genes[1][3][9]. LincRNAs function primarily at the RNA level rather than being translated into proteins. General functions described for lincRNAs include the regulation of gene expression by remodeling chromatin, controlling transcription (sometimes acting as enhancers), modulating RNA stability, and mediating tissue-specific or context-specific gene regulatory functions[9][5]. Specific molecular or disease associations for LINC02591 itself are not reported in current databases, and there are no known drugs targeting it[1][3]. Thus, LINC02591 is not recognized as a therapeutic target, receptor, enzyme, transporter, or other pharmacologically actionable biomolecule at present.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2591 (LINC02591).